Phase 3 trial evaluates encorafenib, cetuximab, and chemotherapy in untreated BRAF V600E-mutant metastatic colorectal cancer, ...

Discover how catheter ablation performs in congenital heart disease - find out more about the latest nationwide results.

Vepdegestrant may prolong progression-free survival in ESR1-mutated, ER-positive, HER2-negative advanced breast cancer, ...

Discover a study that found that the proportion of radical prostatectomies fell from 32.4% in 2010 to just 7.8% by 2020.

A 14-gene molecular assay may help identify early-stage non-squamous NSCLC patients who benefit from chemotherapy ...

ALTHOUGH the incidence of new dementia diagnoses among older Americans has declined in recent years, the overall number of ...

A two-dose primary schedule without booster can provide sufficient protection in high-transmission, resource-limited settings ...

Discover a study that suggests that the infant’s gut microbiota may play a role in both allergy development and tolerance.

Vagus nerve stimulation improves sleep, mood, and life quality in adult epilepsy patients, with early and sustained effects ...

Next-generation metagenomic sequencing has uncovered key differences in bronchiectasis pathogens and resistance genes across Europe.

Final OS results from INAVO120 show inavolisib plus palbociclib and fulvestrant significantly improves survival, delays ...

Vepdegestrant, an oral PROTAC, nearly doubles progression-free survival in ESR1-mutated, ER-positive advanced breast cancer, ...